IP Library › Granted Patent US 12,667,420
Granted Patent B2
US 12,667,420 · App. 17/171,837 · Granted Jun 30, 2026

Catheter ablation device with impedance monitoring

Inventors: Pierre Qian (New South Wales, AU); Michael Anthony Barry (New South Wales, AU)
Assignees: The University of Sydney; Western Sydney Local Health District
A61B18/1815A61B2018/00577A61B2018/00875A61B2018/1823A61B2018/1861A61B2218/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,667,420
App. No.
17/171,837
Filed
Feb 9, 2021
Granted
Jun 30, 2026
Kind
B2
Art Unit
3794
USPC
606/33
Abstract

The invention relates to a catheter ablation device for delivery of energy (such as microwave energy) via a radiating antenna to a selected region of tissue, the device having an elongated catheter with an outer sheath, configured to allow flow of fluid along the catheter to exit through one or more orifices adjacent to the antenna. The device includes an impedance monitoring system having two electrodes arranged respectively inside and outside said catheter sheath, the impedance monitoring system including an electric circuit incorporating an ionic conductivity path through said fluid. The device is introduced into a blood vessel and the invention allows monitoring of changes in the size of the blood vessel during an ablation procedure, as it can be used to measure the impedance of an electrical circuit including a blood path in the blood vessel in the region of the ablation, the measured impedance providing a measure of vascular calibre.

Claims (17)

1 . A microwave catheter ablation device for delivery of energy to a selected region of tissue, the microwave catheter ablation device comprising:

an electrical feedline;

an antenna portion including a radiating antenna electrically connectable via the electrical feedline to a microwave generator and configured to generate an electromagnetic field comprising electromagnetic waves in a microwave energy spectrum able to ablate tissue in the selected region of tissue;

an elongated catheter having a distal tip, an outer sheath and one or more orifices formed through the outer sheath in or adjacent to the antenna portion, wherein the outer sheath is configured to allow a flow of fluid along the catheter to exit through the one or more orifices; and

an impedance monitoring system comprising first and second electrodes positioned along a length of the catheter at locations spaced apart from the distal tip, wherein the first and second electrodes are arranged respectively inside and outside the outer sheath and configured such that in use the impedance monitoring system applies an electrical signal to create an electric circuit incorporating an ionic conductivity path through the fluid between the first electrode and the second electrode via the one or more orifices and the impedance monitoring system measures the impedance of the ionic conductivity path;

wherein the second electrode is separate to the radiating antenna.

2 . The device of claim 1 , wherein the first and second electrodes are arranged proximal of the antenna portion.

3 . The device of claim 1 , wherein the first and second electrodes are electrically connectable to an impedance monitor configured to provide an indication to a user of the device of a measure of an impedance of the electric circuit.

4 . The device of claim 1 , wherein one or both of the first and second electrodes comprise ring or part-ring form electrodes.

5 . The device of claim 1 , wherein the first electrode arranged on the inside of the outer sheath is supported on an outside surface of the electrical feedline.

6 . The device of claim 1 , wherein the second electrode arranged on the outside of the catheter sheath is supported on an outside surface of the catheter sheath.

7 . The device of claim 1 , wherein one or both of the first and second electrodes is embedded into a wall of the catheter sheath.

8 . The device of claim 1 , wherein the outer catheter sheath is sized to provide sufficient internal free space around the feedline to allow a flow of fluid through the catheter from a proximal end and exiting the catheter through the one or more orifices at a distal end.

9 . The device of claim 8 wherein the one or more orifices are arranged radially around the outer sheath.

10 . The device of claim 1 , wherein the first and second electrodes are positioned at approximately at the same axial position along the catheter.

11 . The device of claim 1 , wherein the ionic conductivity path extends within the catheter from the first electrode to the one or more orifices and extends from the one or more orifices to the second electrode outside of the catheter.

12 . The device of claim 1 , wherein the first and second electrodes are each formed by stripped ends of wires, the wires running a length of the catheter from a proximal end of the catheter.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2021
From: QIAN, PIERRE; BARRY, MICHAEL ANTHONY
To: THE UNIVERSITY OF SYDNEY; WESTERN SYDNEY LOCAL HEALTH DISTRICT
Reel/Frame 056013/0408 →
Priority Claims (1)
AU 2018902954 · Aug 13, 2018 · national
Continuity (2)
Continuation PCTAU2019050844 · Aug 13, 2019
Related Publication 20210186609A1 · Jun 24, 2021
References Cited (118)
US 4920980A · Jackowski · 1990 [cited by applicant]
US 5328471A · Slepian · 1994 [cited by applicant]
US 5662680A · Desai · 1997 [cited by applicant]
US 6027500A · Buckles et al. · 2000 [cited by applicant]
US 6210367B1 · Carr · 2001 [cited by applicant]
US 6635055B1 · Cronin · 2003 [cited by applicant]
US 7566341B2 · Keller et al. · 2009 [cited by applicant]
US 8382750B2 · Brannan · 2013 [cited by applicant]
US 11324408B2 · Wang · 2022 [cited by applicant]
US 11701158B2 · Chou · 2023 [cited by examiner]
US 20040049254A1 · Longo · 2004 [cited by applicant]
US 20050267463A1 · Vanney · 2005 [cited by applicant]
US 20070066972A1 · Ormsby et al. · 2007 [cited by applicant]
US 20070203551A1 · Cronin et al. · 2007 [cited by applicant]
US 20080183169A1 · Klimovitch et al. · 2008 [cited by applicant]
US 20080294041A1 · Kassab · 2008 [cited by applicant]
US 20090062684A1 · Gregersen et al. · 2009 [cited by applicant]
US 20090240249A1 · Chan et al. · 2009 [cited by applicant]
US 20100069921A1 · Miller et al. · 2010 [cited by applicant]
US 20100198040A1 · Friedman et al. · 2010 [cited by applicant]
US 20100262137A1 · Nye et al. · 2010 [cited by applicant]
US 20110040162A1 · Kinnison · 2011 [cited by applicant]
US 20110082383A1 · Cory et al. · 2011 [cited by applicant]
US 20110291736A1 · Klimovitch et al. · 2011 [cited by applicant]
US 20110306867A1 · Gopinathan et al. · 2011 [cited by applicant]
US 20120116486A1 · Naga et al. · 2012 [cited by applicant]
US 20120157988A1 · Stone et al. · 2012 [cited by applicant]
US 20120259326A1 · Brannan et al. · 2012 [cited by applicant]
US 20120265200A1 · Curley · 2012 [cited by applicant]
US 20130226169A1 · Miller et al. · 2013 [cited by applicant]
US 20130296840A1 · Condie et al. · 2013 [cited by applicant]
US 20140018788A1 · Engelman et al. · 2014 [cited by applicant]
US 20140046174A1 · Ladtkow et al. · 2014 [cited by applicant]
US 20140257130A1 · Cao et al. · 2014 [cited by applicant]
US 20140276743A1 · Curley · 2014 [cited by examiner]
US 20150080875A1 · Kasprzyk et al. · 2015 [cited by applicant]
US 20150105765A1 · Panescu et al. · 2015 [cited by applicant]
US 20160081744A1 · Wang · 2016 [cited by applicant]
US 20160095535A1 · Hettrick et al. · 2016 [cited by applicant]
US 20160184008A1 · Papaioannou et al. · 2016 [cited by applicant]
US 20160199127A1 · Prutchi · 2016 [cited by applicant]
US 20160242667A1 · Fay et al. · 2016 [cited by applicant]
US 20160262777A1 · Stigall et al. · 2016 [cited by applicant]
US 20170095290A1 · Sherman et al. · 2017 [cited by applicant]
US 20170143414A1 · Sliwa et al. · 2017 [cited by applicant]
US 20170252101A1 · Hata et al. · 2017 [cited by applicant]
US 20170354364A1 · Bar-Tal et al. · 2017 [cited by applicant]
US 20180125575A1 · Schwartz et al. · 2018 [cited by applicant]
US 20180289284A1 · Panescu et al. · 2018 [cited by applicant]
US 20180338703A1 · Sulkin et al. · 2018 [cited by applicant]
US 20190167147A1 · Kassab · 2019 [cited by examiner]
US 20190374285A1 · Hancock et al. · 2019 [cited by applicant]
US 20200375658A1 · Qian et al. · 2020 [cited by applicant]
US 20210186608A1 · Qian et al. · 2021 [cited by applicant]
US 20210196378A1 · Qian et al. · 2021 [cited by applicant]
US 20210251688A1 · Dickhans et al. · 2021 [cited by applicant]
US 20210401495A1 · Qian et al. · 2021 [cited by applicant]
AU 2006292698A1 · 2007 [cited by applicant]
CN 101969875A · 2011 [cited by applicant]
CN 103096826A · 2013 [cited by applicant]
CN 103860266A · 2014 [cited by applicant]
CN 105263432A · 2016 [cited by applicant]
CN 103096826B · 2016 [cited by applicant]
EP 2460486A1 · 2012 [cited by applicant]
GB 250673A · 1926 [cited by applicant]
JP 57187505U · 1982 [cited by applicant]
JP 6216755A · 1987 [cited by applicant]
JP 08187297A · 1996 [cited by applicant]
JP 2002065693A · 2002 [cited by applicant]
JP 2003514635A · 2003 [cited by applicant]
JP 2009285463A · 2009 [cited by applicant]
JP 2011511424A · 2011 [cited by applicant]
JP 2011511538A · 2011 [cited by applicant]
JP 2012506300A · 2012 [cited by applicant]
JP 2014525814A · 2014 [cited by applicant]
JP 2016532497A · 2016 [cited by applicant]
JP 2018522612A · 2018 [cited by applicant]
JP 2019500170A · 2019 [cited by applicant]
JP 2021531841A · 2021 [cited by applicant]
WO 9835611A1 · 1998 [cited by applicant]
WO 9849957A1 · 1998 [cited by applicant]
WO 9956642A1 · 1999 [cited by applicant]
WO 0035363A1 · 2000 [cited by applicant]
WO 02061880A2 · 2002 [cited by applicant]
WO 2009094392A2 · 2009 [cited by applicant]
WO 2009098513A1 · 2009 [cited by applicant]
WO 2011060200A1 · 2011 [cited by applicant]
WO 2012058434A1 · 2012 [cited by applicant]
WO 2014188430A2 · 2014 [cited by applicant]
WO 2016054379A1 · 2016 [cited by applicant]
WO 2016090175A1 · 2016 [cited by applicant]
WO 2016197206A1 · 2016 [cited by applicant]
WO 2017056056A1 · 2017 [cited by applicant]
WO 2017093926A1 · 2017 [cited by applicant]
WO 2018023132A1 · 2018 [cited by applicant]
WO 2018027174A1 · 2018 [cited by applicant]
WO 2018081540A1 · 2018 [cited by applicant]
U.S. Appl. No. 16/994,134, “Non-Final Office Action”, Oct. 24, 2023, 7 pages. [cited by applicant]
U.S. Appl. No. 17/142,943, “Non-Final Office Action”, Oct. 18, 2023, 14 pages. [cited by applicant]
U.S. Appl. No. 17/171,878, “Non-Final Office Action”, Nov. 21, 2023, 13 pages. [cited by applicant]
CN202080027495.0, “Office Action”, Dec. 26, 2023, 12 pages. [cited by applicant]
JP2021-549554, “Office Action”, Dec. 1, 2023, 11 pages. [cited by applicant]
Chen, et al., “Renal Artery Vasodilation May Be An Indicator of Successful Sympathetic Nerve Damage During Renal Denervation Procedure”, Scientific Reports, vol. 6, No. 37218, Nov. 16, 2016, pp. 1-10. [cited by applicant]
JP2020-572968, “Japanese Office Action”, May 11, 2023, pp. 1-7. [cited by applicant]
Chen, et al., “Renal Artery Vasodilation May Be An Indicator of Successful Sympathetic Nerve Damage During Renal Denervation Procedure”, Scientific Reports, vol. 6, Nov. 16, 2016, pp. 1-10. [cited by applicant]
Doltra, et al., “Effects of Renal Denervation on Renal Artery Function in Humans: Preliminary Study”, Plos One, vol. 11, No. 3, Mar. 22, 2016, pp. 1-14. [cited by applicant]
PCT/AU2019/050844, “International Search Report and Written Opinion”, Oct. 24, 2019, 9 pages. [cited by applicant]
JP2020572955, “Office Action”, May 22, 2023, pp. 1-11. [cited by applicant]
201980053897.5, “CN Office Action”, Nov. 20, 2023, pp. 1-15. [cited by applicant]
19850301.3, “European Search Report”, Apr. 8, 2022, pp. 1-7. [cited by applicant]
U.S. Appl. No. 17/142,943, “Advisory Action”, Aug. 22, 2024, 3 pages. [cited by applicant]
U.S. Appl. No. 17/142,943 , Non-Final Office Action, Mailed On Oct. 24, 2024, 16 pages. [cited by applicant]
U.S. Appl. No. 17/468,420 , Non-Final Office Action, Mailed On Nov. 7, 2024, 12 pages. [cited by applicant]
U.S. Appl. No. 17/142,943, “Final Office Action”, Jun. 5, 2024, 18 pages. [cited by applicant]
U.S. Appl. No. 17/468,420, “Non-Final Office Action”, Jun. 6, 2024, 14 pages. [cited by applicant]
U.S. Appl. No. 17/142,943, “Final Office Action”, Apr. 10, 2025, 24 pages. [cited by applicant]
U.S. Appl. No. 17/468,420, “Final Office Action”, Apr. 18, 2025, 14 pages. [cited by applicant]
U.S. Appl. No. 17/468,420, “Non-Final Office Action”, Apr. 6, 2026, 40 pages. [cited by applicant]